# Richard G. Moore

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/richard-g-moore/

## Facts

| Field | Value |
| --- | --- |
| Citations | 15,247 |
| Field | Ovarian cancer diagnosis and treatment |
| h-index | 55 |
| i10-index | 138 |
| Last Known Institution | University of Rochester Medicine |
| OpenAlex ID | https://openalex.org/A5052236281 |
| ORCID iD | 0000-0001-5598-5263 |
| Works | 342 |

## Researcher papers

- [Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer](https://scholariq.org/papers/niraparib-in-patients-with-newly-diagnosed-advanced-ovarian-cancer/)
- [Metacognitive awareness and prevention of relapse in depression: Empirical evidence.](https://scholariq.org/papers/metacognitive-awareness-and-prevention-of-relapse-in-depression-empirical/)
- [Metacognitive awareness and prevention of relapse in depression: Empirical evidence.](https://scholariq.org/papers/metacognitive-awareness-and-prevention-of-relapse-in-depression-empirical-2/)
- [A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass](https://scholariq.org/papers/a-novel-multiple-marker-bioassay-utilizing-he4-and-ca125-for-the-prediction-of/)
- [Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer](https://scholariq.org/papers/pembrolizumab-plus-chemotherapy-in-advanced-endometrial-cancer/)
- [The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass](https://scholariq.org/papers/the-use-of-multiple-novel-tumor-biomarkers-for-the-detection-of-ovarian/)
- [Prevention of relapse in residual depression by cognitive therapy: a controlled trial.](https://scholariq.org/papers/prevention-of-relapse-in-residual-depression-by-cognitive-therapy-a-controlled/)
- [Comparison of a novel multiple marker assay vs the Risk of Malignancy Index for the prediction of epithelial ovarian cancer in patients with a pelvic mass](https://scholariq.org/papers/comparison-of-a-novel-multiple-marker-assay-vs-the-risk-of-malignancy-index-for/)
- [Evaluation of the Diagnostic Accuracy of the Risk of Ovarian Malignancy Algorithm in Women With a Pelvic Mass](https://scholariq.org/papers/evaluation-of-the-diagnostic-accuracy-of-the-risk-of-ovarian-malignancy/)
- [Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus](https://scholariq.org/papers/utility-of-a-novel-serum-tumor-biomarker-he4-in-patients-with-endometrioid/)

## Researcher topics

- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)
- [Endometrial and Cervical Cancer Treatments](https://scholariq.org/topics/endometrial-and-cervical-cancer-treatments/)
- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)
- [Psychotherapy Techniques and Applications](https://scholariq.org/topics/psychotherapy-techniques-and-applications/)
- [Endometriosis Research and Treatment](https://scholariq.org/topics/endometriosis-research-and-treatment/)

## Researcher university

- [University of Rochester Medicine](https://scholariq.org/institutions/university-of-rochester-medicine/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.